Friday - February 13, 2026
AARP Rx Price Watch Report Shows Overall Decline in Brand-Name Drug Prices in 2024, But Prices Remain High
February 13, 2026
WASHINGTON, Feb. 13 -- AARP issued the following news release:

* * *

New AARP Rx Price Watch Report Shows Overall Decline in Brand-Name Drug Prices in 2024, But Prices Remain High

Findings highlight the power drug companies have to voluntarily lower prices for consumers and why legislative reforms like Medicare drug price negotiation remain essential

*

AARP's latest Rx Price Watch Report finds that retail prices for brand-name . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products